Have a feature idea you'd love to see implemented? Let us know!

CTHR Charles & Colvard Ltd

Price (delayed)

$1.45

Market cap

$4.4M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.9

Enterprise value

-$2.02M

Charles & Colvard, Ltd. believes fine jewelry can be accessible, beautiful and conscientious. Charles & Colvard is the original pioneer of lab-created moissanite, a rare gemstone formed from silicon carbide. ...

Highlights
CTHR's net income has plunged by 78% YoY but it is up by 21% from the previous quarter
The EPS has dropped by 74% year-on-year but it has grown by 21% since the previous quarter
The company's gross profit has shrunk by 93% YoY and by 49% QoQ
CTHR's gross margin has dropped by 90% year-on-year and by 46% since the previous quarter

Key stats

What are the main financial stats of CTHR
Market
Shares outstanding
3.03M
Market cap
$4.4M
Enterprise value
-$2.02M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.14
Price to sales (P/S)
0.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.09
Earnings
Revenue
$23.68M
Gross profit
$988,851
Net income
-$18.29M
EBIT
-$18.23M
EBITDA
-$17.53M
Free cash flow
-$7.17M
Per share
EPS
-$5.9
EPS diluted
-$5.9
Free cash flow per share
-$2.36
Book value per share
$10.19
Revenue per share
$7.81
TBVPS
$13.39
Balance sheet
Total assets
$40.96M
Total liabilities
$10.04M
Debt
$2.82M
Equity
$30.93M
Working capital
$12.67M
Liquidity
Debt to equity
0.09
Current ratio
2.47
Quick ratio
1.17
Net debt/EBITDA
0.37
Margins
EBITDA margin
-74%
Gross margin
4.2%
Net margin
-77.2%
Operating margin
-78.6%
Efficiency
Return on assets
-40.4%
Return on equity
-51.4%
Return on invested capital
-66%
Return on capital employed
-56.4%
Return on sales
-77%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CTHR stock price

How has the Charles & Colvard stock price performed over time
Intraday
5.84%
1 week
-14.96%
1 month
9.02%
1 year
-66.2%
YTD
-64.63%
QTD
-16.18%

Financial performance

How have Charles & Colvard's revenue and profit performed over time
Revenue
$23.68M
Gross profit
$988,851
Operating income
-$18.6M
Net income
-$18.29M
Gross margin
4.2%
Net margin
-77.2%
The net margin has plunged by 153% YoY but it has grown by 16% from the previous quarter
The company's gross profit has shrunk by 93% YoY and by 49% QoQ
CTHR's gross margin has dropped by 90% year-on-year and by 46% since the previous quarter
CTHR's net income has plunged by 78% YoY but it is up by 21% from the previous quarter

Growth

What is Charles & Colvard's growth rate over time

Valuation

What is Charles & Colvard stock price valuation
P/E
N/A
P/B
0.14
P/S
0.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.09
The EPS has dropped by 74% year-on-year but it has grown by 21% since the previous quarter
The P/B is 83% below the 5-year quarterly average of 0.8 and 72% below the last 4 quarters average of 0.5
The equity is down by 37% YoY and by 10% QoQ
The stock's price to sales (P/S) is 83% less than its 5-year quarterly average of 1.1 and 68% less than its last 4 quarters average of 0.6
The revenue has contracted by 30% YoY and by 6% from the previous quarter

Efficiency

How efficient is Charles & Colvard business performance
The return on equity has dropped by 179% year-on-year but it rose by 10% since the previous quarter
CTHR's ROA has plunged by 156% YoY but it is up by 14% from the previous quarter
The return on invested capital has declined by 22% since the previous quarter
The return on sales has declined by 15% since the previous quarter

Dividends

What is CTHR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CTHR.

Financial health

How did Charles & Colvard financials performed over time
CTHR's quick ratio has dropped by 64% year-on-year and by 24% since the previous quarter
CTHR's current ratio has dropped by 51% year-on-year and by 13% since the previous quarter
The debt is 91% less than the equity
The debt to equity has surged by 50% year-on-year and by 29% since the previous quarter
The equity is down by 37% YoY and by 10% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.